Robbie Marcus
Stock Analyst at JP Morgan
(4.08)
# 406
Out of 4,828 analysts
158
Total ratings
56.48%
Success rate
9.04%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Overweight | $128 → $105 | $95.11 | +10.40% | 6 | May 6, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underweight | $24 → $12 | $12.89 | -6.90% | 6 | May 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $235 → $195 | $152.79 | +27.63% | 5 | May 6, 2025 | |
| CNMD CONMED | Maintains: Neutral | $70 → $58 | $57.75 | +0.43% | 7 | May 1, 2025 | |
| RXST RxSight | Downgrades: Underweight | $40 → $17 | $13.23 | +28.50% | 5 | Apr 4, 2025 | |
| MMSI Merit Medical Systems | Initiates: Overweight | $120 | $96.09 | +24.88% | 1 | Mar 28, 2025 | |
| COO The Cooper Companies | Maintains: Overweight | $120 → $110 | $82.92 | +32.66% | 4 | Mar 7, 2025 | |
| BAX Baxter International | Maintains: Neutral | $38 → $36 | $31.20 | +15.38% | 17 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Overweight | $420 → $445 | $382.46 | +16.35% | 9 | Jan 29, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $575 → $675 | $538.16 | +25.43% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $9 → $14 | $12.55 | +11.55% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $6.80 | +91.18% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $103.29 | +6.50% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $257.00 | +28.40% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $17.10 | +87.13% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $31.18 | +28.29% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $78 | $74.63 | +4.52% | 4 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $85 | $85.34 | -0.40% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $70.50 | +27.66% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $33.08 | +51.15% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $7.54 | +6.10% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $36 → $13 | $7.78 | +67.10% | 5 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $288.73 | -13.41% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $16 | $9.19 | +74.10% | 3 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $6.35 | +10.24% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $17 | $11.50 | +47.83% | 2 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $134.00 | -11.94% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $137.00 | +13.87% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $130 → $105 | $83.62 | +25.57% | 11 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $90.54 | -55.82% | 2 | May 5, 2020 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Overweight
Price Target: $128 → $105
Current: $95.11
Upside: +10.40%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Underweight
Price Target: $24 → $12
Current: $12.89
Upside: -6.90%
Inspire Medical Systems
May 6, 2025
Maintains: Overweight
Price Target: $235 → $195
Current: $152.79
Upside: +27.63%
CONMED
May 1, 2025
Maintains: Neutral
Price Target: $70 → $58
Current: $57.75
Upside: +0.43%
RxSight
Apr 4, 2025
Downgrades: Underweight
Price Target: $40 → $17
Current: $13.23
Upside: +28.50%
Merit Medical Systems
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $96.09
Upside: +24.88%
The Cooper Companies
Mar 7, 2025
Maintains: Overweight
Price Target: $120 → $110
Current: $82.92
Upside: +32.66%
Baxter International
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $31.20
Upside: +15.38%
Stryker
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $382.46
Upside: +16.35%
Intuitive Surgical
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $538.16
Upside: +25.43%
Dec 17, 2024
Maintains: Overweight
Price Target: $9 → $14
Current: $12.55
Upside: +11.55%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $6.80
Upside: +91.18%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $103.29
Upside: +6.50%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $257.00
Upside: +28.40%
Nov 5, 2024
Initiates: Overweight
Price Target: $32
Current: $17.10
Upside: +87.13%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $31.18
Upside: +28.29%
Oct 25, 2024
Maintains: Neutral
Price Target: $72 → $78
Current: $74.63
Upside: +4.52%
Oct 25, 2024
Maintains: Neutral
Price Target: $75 → $85
Current: $85.34
Upside: -0.40%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $70.50
Upside: +27.66%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $33.08
Upside: +51.15%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $7.54
Upside: +6.10%
May 1, 2024
Downgrades: Neutral
Price Target: $36 → $13
Current: $7.78
Upside: +67.10%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $288.73
Upside: -13.41%
Dec 20, 2023
Maintains: Neutral
Price Target: $10 → $16
Current: $9.19
Upside: +74.10%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $6.35
Upside: +10.24%
Feb 23, 2023
Maintains: Neutral
Price Target: $15 → $17
Current: $11.50
Upside: +47.83%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $134.00
Upside: -11.94%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $137.00
Upside: +13.87%
Dec 17, 2021
Downgrades: Neutral
Price Target: $130 → $105
Current: $83.62
Upside: +25.57%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $90.54
Upside: -55.82%